<DOC>
	<DOCNO>NCT02303184</DOCNO>
	<brief_summary>A phase 2 , multicenter , randomize , active-controlled , mask , parallel arm study design evaluate safety efficacy single suprachoroidal injection CLS-TA , triamcinolone acetonide injectable suspension , give along intravitreal ( IVT ) injection aflibercept compare IVT aflibercept alone subject retinal vein occlusion ( RVO ) .</brief_summary>
	<brief_title>Suprachoroidal Injection Triamcinolone Acetonide With IVT Aflibercept Subjects With Macular Edema Following RVO</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<criteria>diagnosis macular edema follow RVO History ME â‰¤ 12 month 2070 letter inclusive BCVA use ETDRS IVT injection antiVEGF RVO study eye corticosteroid injection past 3 month study eye uncontrolled ophthalmic condition study eye RVO</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>RVO</keyword>
	<keyword>ME</keyword>
	<keyword>Central Subfield Thickness</keyword>
	<keyword>OCT</keyword>
	<keyword>optical coherence tomography</keyword>
	<keyword>cystoid macular edema</keyword>
	<keyword>subretinal fluid</keyword>
	<keyword>Eylea</keyword>
	<keyword>aflibercept</keyword>
	<keyword>anti-VEGF</keyword>
</DOC>